BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24427762)

  • 1. Microneedle patches for vaccine delivery.
    Suh H; Shin J; Kim YC
    Clin Exp Vaccine Res; 2014 Jan; 3(1):42-9. PubMed ID: 24427762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microneedle Patches as Drug and Vaccine Delivery Platform.
    Li J; Zeng M; Shan H; Tong C
    Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microneedles for vaccine delivery: challenges and future perspectives.
    Shin CI; Jeong SD; Rejinold NS; Kim YC
    Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedles: A New Generation Vaccine Delivery System.
    Menon I; Bagwe P; Gomes KB; Bajaj L; Gala R; Uddin MN; D'Souza MJ; Zughaier SM
    Micromachines (Basel); 2021 Apr; 12(4):. PubMed ID: 33919925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.
    Weldon WC; Martin MP; Zarnitsyn V; Wang B; Koutsonanos D; Skountzou I; Prausnitz MR; Compans RW
    Clin Vaccine Immunol; 2011 Apr; 18(4):647-54. PubMed ID: 21288996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice.
    Carey JB; Pearson FE; Vrdoljak A; McGrath MG; Crean AM; Walsh PT; Doody T; O'Mahony C; Hill AV; Moore AC
    PLoS One; 2011; 6(7):e22442. PubMed ID: 21799855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.
    Song JM; Kim YC; Lipatov AS; Pearton M; Davis CT; Yoo DG; Park KM; Chen LM; Quan FS; Birchall JC; Donis RO; Prausnitz MR; Compans RW; Kang SM
    Clin Vaccine Immunol; 2010 Sep; 17(9):1381-9. PubMed ID: 20631330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal influenza immunization with vaccine-coated microneedle arrays.
    Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I
    PLoS One; 2009; 4(3):e4773. PubMed ID: 19274084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
    Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K
    Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens.
    Kommareddy S; Baudner BC; Oh S; Kwon SY; Singh M; O'Hagan DT
    J Pharm Sci; 2012 Mar; 101(3):1021-7. PubMed ID: 22190403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
    Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
    PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection.
    Koutsonanos DG; Vassilieva EV; Stavropoulou A; Zarnitsyn VG; Esser ES; Taherbhai MT; Prausnitz MR; Compans RW; Skountzou I
    Sci Rep; 2012; 2():357. PubMed ID: 22500210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
    Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
    J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microneedle technologies for (trans)dermal drug and vaccine delivery.
    van der Maaden K; Jiskoot W; Bouwstra J
    J Control Release; 2012 Jul; 161(2):645-55. PubMed ID: 22342643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in microneedle array patch (MAP) for vaccine delivery.
    Nguyen TT; Oh Y; Kim Y; Shin Y; Baek SK; Park JH
    Hum Vaccin Immunother; 2021 Jan; 17(1):316-327. PubMed ID: 32667239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolving polymer microneedle patches for influenza vaccination.
    Sullivan SP; Koutsonanos DG; Del Pilar Martin M; Lee JW; Zarnitsyn V; Choi SO; Murthy N; Compans RW; Skountzou I; Prausnitz MR
    Nat Med; 2010 Aug; 16(8):915-20. PubMed ID: 20639891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
    Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
    Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
    Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
    J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.